Atara Biotherapeutics (ATRA) Liabilities and Shareholders Equity (2013 - 2026)
Atara Biotherapeutics (ATRA) reported Liabilities and Shareholders Equity of $21.02 million for Q2 2026, down 43.0% from $36.9 million a year earlier but up 5.1% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Atara Biotherapeutics posted Liabilities and Shareholders Equity of $20.24 million, down 81.5% from FY2024.
- Liabilities and Shareholders Equity has declined for five consecutive years, with a five-year compound annual growth rate of -49.0% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $109.1 million in FY2024 (-34.1%), $165.5 million in FY2023 (-56.0%), $376.42 million in FY2022 (-19.6%) and $468.13 million in FY2021 (-20.4%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $20 million in Q1 2026 and a high of $468.13 million in Q4 2021.
- Year over year, Liabilities and Shareholders Equity has now declined in each of the last 19 quarters, with an average decline of 57.6% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q3 2021 (growth of 10.9%); the low point was Q4 2025 (a decline of 81.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $20 million (Q1 2026), $20.24 million (Q4 2025) and $30.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | 21.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.02 Mn |
| Mar 31, 2026 | 20.00 Mn |
| Dec 31, 2025 | 20.24 Mn |
| Sep 30, 2025 | 30.17 Mn |
| Jun 30, 2025 | 36.90 Mn |
| Mar 31, 2025 | 62.04 Mn |
| Dec 31, 2024 | 109.10 Mn |
| Sep 30, 2024 | 142.71 Mn |
| Jun 30, 2024 | 117.28 Mn |
| Mar 31, 2024 | 165.27 Mn |
| Dec 31, 2023 | 165.50 Mn |
| Sep 30, 2023 | 188.79 Mn |
| Jun 30, 2023 | 246.44 Mn |
| Mar 31, 2023 | 302.08 Mn |
| Dec 31, 2022 | 376.42 Mn |
| Sep 30, 2022 | 368.32 Mn |
| Jun 30, 2022 | 436.12 Mn |
| Mar 31, 2022 | 397.28 Mn |
| Dec 31, 2021 | 468.13 Mn |
| Sep 30, 2021 | 449.92 Mn |
API Access
Atara Biotherapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();